Elekta AB Class B

EKTA B: XSTO (SWE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
k%LOCK|!dwLOCK|BCYLn%^

Elekta's Struggles Continue but Pipeline Looks Promising

Business Strategy and Outlook

Demand for radiotherapy should stay healthy over the next decade. Elekta stands to benefit, but its success depends on the continuing adoption of Unity, success of its refreshed product and software offering, as well as its ability to withstand competition from Siemens Healthineers.

Sponsor Center